- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cosmos Pharmaceutical Corp (3349)
Cosmos Pharmaceutical Corp stock price live, this page displays TYO 3349 stock exchange data. View the 3349 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cosmos Pharmaceutical Corp real time stock price chart below.
What Is the Cosmos Pharmaceutical Corp Stock Price Today?
The Cosmos Pharmaceutical Corp stock price today is 6,643.0.
What Is the Stock Symbol for Cosmos Pharmaceutical Corp?
The stock symbol for Cosmos Pharmaceutical Corp is "3349."
What Stock Exchange Does Cosmos Pharmaceutical Corp Trade On?
Cosmos Pharmaceutical Corp is listed and trades on the Tokyo stock exchange.
Is Cosmos Pharmaceutical Corp a Good Stock to Buy?
Determining whether Cosmos Pharmaceutical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 3349 quote. (ISIN: JP3298400007)
What Is the Cosmos Pharmaceutical Corp Stock Price Today?
The Cosmos Pharmaceutical Corp stock price today is 6,643.0.
What Is the Stock Symbol for Cosmos Pharmaceutical Corp?
The stock symbol for Cosmos Pharmaceutical Corp is "3349."
What Stock Exchange Does Cosmos Pharmaceutical Corp Trade On?
Cosmos Pharmaceutical Corp is listed and trades on the Tokyo stock exchange.
Is Cosmos Pharmaceutical Corp a Good Stock to Buy?
Determining whether Cosmos Pharmaceutical Corp—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 3349 quote. (ISIN: JP3298400007)
Tokyo
Currency in JPY
6,643.0
+156.0(+2.40%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6,475.0
6,666.0
52 wk Range
5,615.0
8,980.0
3349 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
6,475.06,666.0
52 wk Range
5,615.08,980.0
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.33%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
3349 Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
7,620.0
Upside
+14.71%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
5 Buy
5 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 7,620.0
(+14.71% Upside)
Earnings
Latest Release
Jul 13, 2026
EPS / Forecast
117.31 / 113.22
Revenue / Forecast
289.2B / 285.86B
Compare 3349 to Peers and Sector
Metrics to compare | 3349 | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship Relationship3349PeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.8x | 14.6x | 11.2x | |
PEG Ratio | 4.77 | 0.27 | 0.03 | |
Price/Book | 1.9x | 1.4x | 1.5x | |
Price / LTM Sales | 0.5x | 0.4x | 0.9x | |
Upside (Analyst Target) | 14.7% | 15.6% | 26.6% | |
Fair Value Upside | Unlock | 18.9% | 13.7% | Unlock |
COSMOS Pharmaceutical Corporation engages in the retail sale of pharmaceuticals, cosmetics, daily necessities, and food products in Japan. The company offers general medicines, energy drinks, oral and nursing care products, vitamins, health foods, diet foods, and prescriptions; and hair care and bath products. It also provides baby products, detergents, insect repellents, air fresheners, bath and toilet products, cooking supplies, gardening supplies, household and cleaning supplies, and clothing; processed foods, daily necessities, seasonings, confectionery, beverages, and alcohol; and tobacco and other products. In addition, the company engages in the maintenance and management of buildings and commercial facilities, traffic control, and security contracting activities. It sells its products through retail stores and online. COSMOS Pharmaceutical Corporation was incorporated in 1983 and is headquartered in Fukuoka City, Japan.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Cosmos Pharmaceutical Corp (3349) Stock Price Today?
The Cosmos Pharmaceutical Corp stock price today is 6,643.0 JPY.
What Stock Exchange Does Cosmos Pharmaceutical Corp Trade On?
Cosmos Pharmaceutical Corp is listed and trades on the Tokyo Stock Exchange.
What Is the Stock Symbol for Cosmos Pharmaceutical Corp?
The stock symbol for Cosmos Pharmaceutical Corp is "3349."
Does Cosmos Pharmaceutical Corp Pay Dividends? What’s The Current Dividend Yield?
The Cosmos Pharmaceutical Corp dividend yield is 1.33%.
What Is the Cosmos Pharmaceutical Corp Market Cap?
As of today, Cosmos Pharmaceutical Corp market cap is 526.51B JPY.
What Is Cosmos Pharmaceutical Corp's Earnings Per Share (TTM)?
The Cosmos Pharmaceutical Corp EPS (TTM) is 404.3.
When Is the Next Cosmos Pharmaceutical Corp Earnings Date?
Cosmos Pharmaceutical Corp will release its next earnings report on Oct 13, 2026.
From a Technical Analysis Perspective, Is 3349 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Cosmos Pharmaceutical Corp Stock Split?
Cosmos Pharmaceutical Corp has split 3 times.
How Many Employees Does Cosmos Pharmaceutical Corp Have?
Cosmos Pharmaceutical Corp has 5984 employees.
What is the current trading status of Cosmos Pharmaceutical Corp (3349)?
As of Sep 17, 2026, Cosmos Pharmaceutical Corp (3349) is trading at a price of 6,643.0 JPY, with a previous close of 6,643.0 JPY. The stock has fluctuated within a day range of 6,475.0 JPY to 6,666.0 JPY, while its 52-week range spans from 5,615.0 JPY to 8,980.0 JPY.
What Is Cosmos Pharmaceutical Corp (3349) Price Target According to Analysts?
The average 12-month price target for Cosmos Pharmaceutical Corp is 7,620.0 JPY, with a high estimate of 9600 JPY and a low estimate of 6700 JPY. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +14.71% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.